confinis is a global consulting firm in the field of medical devices, in vitro diagnostics and combination products based in Switzerland and the USA. Our range of services includes regulatory affairs, quality management, design control, risk management, usability engineering/human factors, clinical evaluation, labelling, manufacturing, process validation, supply chain, post-market monitoring, auditing, and training. Our experienced and highly motivated team consists of electrical, mechanical, software, and biomedical engineers, as well as physicists, pharmacists, medical doctors, chemists, biochemists, biologists, and biotechnologists.


We have mastered the theory, but we still see ourselves as practitioners who have learned from scratch. Our knowledge and skills, based on theoretical foundations, are rounded off with years of practical experience. As a partner, confinis offers its clients pragmatic and workable solutions.

Efficient and effective advice on medical and combination products is not rocket science — it just needs well-founded and updated knowledge as well as decades of experience!

About our clients

Globally active companies

Start-Ups

SMEs

Consulting firms

Overview

switzerland office

confinis ag, Allee 1B,
CH-6210 Sursee, Switzerland

+41 26 494 8 494

info.ch@confinis.com

U.S. office

confinis corp., 15807 Glacier Ct,
North Potomac, MD 20878, USA

+1 240 252 0891

info.usa@confinis.com

Go to article: Home | The implant generation Go to article: BioInteractions Company Insight Go to article: BioInteractions Go to article: In This Issue Go to article: Contents Go to article: NewsGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: The Medical Industry BriefingGo to article: Timeline: the evolution of hearing aidsGo to article: Open wide: how 3D printing is reshaping dentistryGo to article: Regulating implants: how to ensure safety Go to article: Critical Software Company Insight Go to article: Critical SoftwareGo to article: From Grinders to Biohackers: where medical technology meets body modificationGo to article: Coat XGo to article: confinis Company Insight Go to article: confinisGo to article: Q&A: how tech can unleash preventative personalised medicine with VeritaGo to article: No filter: understanding how medicines impact dehydration Go to article: Medical tourism: how is digital tech reshaping the industry?Go to article: Triple combo: calming Alzheimer’s agitation with AI, wearables and a novel drugGo to article: Report raises doubts about influential clinical trial and heart disease guidelinesGo to article: First single-use duodenoscope approved by the FDAGo to article: Key trends of blockchain in healthcare in 2020Go to article: Epidural stimulator may help paralysed individuals regain mobilityGo to article: Debate over reuse of single-use medical devices rages onGo to article: Deals in brief powered by GlobalDataGo to article: The key list powered by GlobalDataGo to article: EventsGo to article: Next issue